Manipal Health Launches Rs 9,275 Crore IPO: Is It a Smart Investment for You?

Manipal Health Enterprises, a prominent healthcare provider in India, launched its IPO for public subscription on July 29, 2023, which will remain open until July 31, 2023. The Bengaluru-based hospital chain is aiming to raise approximately Rs 9,275 crore through this offering, which consists of a fresh issue of 13.56 crore shares worth Rs 8,000 crore and an offer for sale (OFS) of 2.16 crore shares aggregating to about Rs 1,275 crore. The price band for the shares has been set at Rs 560-590. The share allotment is expected to be finalized by August 3, followed by a listing on the NSE and BSE on August 5.

Currently, the grey market sentiment surrounding the IPO reflects a modest premium, with shares indicating a grey market premium (GMP) of around 2%. This translates to an estimated listing price of Rs 598, slightly above the upper end of the issue price at Rs 590. However, investors should approach GMP figures with caution, as it is primarily a sentiment indicator and not a definitive predictor of listing performance. The grey market activity suggests a tempered expectation for listing gains, which may influence investor strategies.

For Indian investors, Manipal Health’s IPO represents both opportunity and caution. While the company holds a robust position in the healthcare market, with plans for expansion and a strategy focused on reducing debt, the premium valuation of 85.4x FY26 earnings raises concerns regarding near-term upside potential. Brokerages are divided, with some recommending a ‘Subscribe’ for long-term investment, while others adopt a neutral stance. Overall, the IPO may better cater to long-term investors looking to capitalize on India’s burgeoning healthcare sector, rather than attract those seeking quick listing gains.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)